new IV antibiotic for methicillin-resistant Staph aureus (MRSA), Vibativ (vy-BA-tiv)

Please see the June 2013 FDA release regarding the expanded use of Vibativ

If you prepare IVs, you'll soon see a new IV antibiotic for methicillin-resistant Staph aureus (MRSA), Vibativ (vy-BA-tiv).

It's related to vancomycin...and has many of vanco's drawbacks.

Vibativ (telavancin) will usually be saved for infections resistant to vancomycin...or as an alternative to vanco like Zyvox (linezolid), Cubicin (daptomycin), and Tygacil (tigecycline).

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote